RCMNY
TEVA icon

Rubric Capital Management (New York)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Rubric Capital Management (New York)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528M Buy
15,575,000
+325,000
+2% +$10.8M 4.84% 4
2026
Q1 		$459M Sell
15,250,000
-6,105,510
-29% -$196M 4.87% 5
2025
Q4 		$667M Sell
21,355,510
-3,294,490
-13% -$81.2M 7.97% 3
2025
Q3 		$498M Sell
24,650,000
-1,350,000
-5% -$23.7M 5.62% 4
2025
Q2 		$436M Buy
26,000,000
+450,000
+2% +$7.26M 6.58% 2
2025
Q1 		$393M Buy
25,550,000
+8,550,000
+50% +$153M 7.04% 2
2024
Q4 		$375M Buy
17,000,000
+994,502
+6% +$18.1M 4.81% 4
2024
Q3 		$288M Sell
16,005,498
-1,256,243
-7% -$22M 4.7% 2
2024
Q2 		$281M Sell
17,261,741
-407,847
-2% -$6.28M 7.35% 1
2024
Q1 		$249M Sell
17,669,588
-557,013
-3% -$7.02M 7.37% 1
2023
Q4 		$190M Sell
18,226,601
-773,399
-4% -$7.22M 3.95% 3
2023
Q3 		$194M Buy
19,000,000
+281,638
+2% +$2.62M 7.27% 2
2023
Q2 		$141M Buy
18,718,362
+14,218,556
+316% +$115M 6.03% 1
2023
Q1 		$39.8M Buy
+4,499,806
New +$44.5M 1.03% 24
2019
Q1 		– Sell
-830,000
Closed -$12.8M – 72
2018
Q4 		$12.8M Buy
+830,000
New +$17M 1.58% 24

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rubric Capital Management (New York)'s TEVA Position: Q2 2026 in Review

Rubric Capital Management (New York) increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.1% in Q2 2026, buying an estimated $10.8M and bringing the position to 15,575,000 shares worth $528M. The position accounts for 4.84% of the portfolio, ranked #4.

Rubric Capital Management (New York) first reported a position in TEVA in Q4 2018 and has held it in 15 quarters since. The position peaked at $667M in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Rubric Capital Management (New York) held 15,575,000 shares of Teva Pharmaceutical Industries Limited worth $528M as of Q2 2026.
  • Rubric Capital Management (New York) bought 325,000 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $10.8M.
  • Teva Pharmaceutical Industries Limited made up 4.84% of Rubric Capital Management (New York)'s portfolio in Q2 2026, its #4 holding.
  • Rubric Capital Management (New York) first reported a position in Teva Pharmaceutical Industries Limited in Q4 2018 and has held it in 15 quarters since.
  • Rubric Capital Management (New York)'s Teva Pharmaceutical Industries Limited position peaked at $667M in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.